Alternatives to Regenxcel
Regenxcel is a Biotech tool: regenxcel AI transforms cell and gene manufacturing with cutting-edge AI technology for enhanced efficiency and precision. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
Regenxcel profileOpen source alternatives (27)More Biotech alternatives
The 20 closest Biotech companies to Regenxcel
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
Cellcolabs55BiotechTel Aviv, Israel$15.5MAI-powered platform for personalized cell therapy development and manufacturing.
- Website ONOneThree Biotech45BiotechNew York City, United States$2.8M
AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.
- Website
AbCellera41BiotechVancouver, Canada$10.0MAI-powered platform for antibody discovery and development to create new medicines.
- Website
Nona Biosciences62BiotechShanghai, ChinaBiotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website
Tenaya Therapeutics55BiotechSouth San Francisco, United States$158.5MBiotechnology company developing gene therapies and regenerative medicine for heart disease.
- Website
Ultragenyx55BiotechNovato, United States$100.0MBiopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
- Website
ProteinQure54BiotechCambridge, United States$15.6MBiotech company using AI and computational platforms to design novel peptide therapeutics.
- Website
Avidity Biosciences53BiotechSan Diego, United States$495.0MClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
- Website
Triomics53BiotechCambridge, United States$22.0MAdvance every cancer decision.
- Website
Syantra53BiotechCalgary, Canada$3.6MA precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
- Website
Bluebird Bio51BiotechSomerville, United States$1.0BGene therapy company developing transformative treatments for severe genetic diseases.
- Website
PFx Biotech51BiotechCambridge, United States$5.2MPFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.
- Website
Orchard Therapeutics51BiotechBoston, United States$125.0MGene therapy company developing treatments for rare inherited diseases.
- Website RIRidge Bio50BiotechSan Francisco, United States$135.0M
Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.
- Website
MacroGenics49BiotechRockville, United States$13.5MBiopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
Showing the 20 closest matches. See the rest on the Regenxcel profile.
Compare Regenxcel head to head
Side by side on what each one does, what it costs, and what real users report.